J Cancer 2018; 9(1):13-20. doi:10.7150/jca.21460 This issue Cite

Research Paper

Inflammatory Response and Toxicity After Pressurized IntraPeritoneal Aerosol Chemotherapy

Hugo Teixeira Farinha*, Fabian Grass*, Ismaïl Labgaa, Basile Pache, Nicolas Demartines, Martin Hübner

Department of Visceral Surgery, University Hospital of Lausanne (CHUV), Switzerland.
* equal contribution

Citation:
Teixeira Farinha H, Grass F, Labgaa I, Pache B, Demartines N, Hübner M. Inflammatory Response and Toxicity After Pressurized IntraPeritoneal Aerosol Chemotherapy. J Cancer 2018; 9(1):13-20. doi:10.7150/jca.21460. https://www.jcancer.org/v09p0013.htm
Other styles

File import instruction

Abstract

Background: Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) is a novel mode of intraperitoneal (IP) drug delivery claiming high IP tissue concentrations with low systemic uptake. The aim was to study inflammatory response and systemic toxicity after PIPAC.

Methods: Retrospective monocentric analysis of a consecutive cohort of PIPAC patients between January 2015 and April 2016. Detailed hematological and biochemical analysis was performed the day before surgery and once daily until discharge. Comparative statistics were performed using Mann-Whitney U test and Wilcoxon signed ranked test.

Results: Fourty-two consecutive patients underwent a total of 91 PIPAC procedures. Twenty patients received oxaliplatin and 22 cisplatin+doxorubicin (37 vs. 54 procedures). Creatinine, AST and ALT were not significantly altered after PIPAC (p=0.095, p= p=0.153 and p=0.351) and not different between oxaliplatin and cisplatin+doxorubicin regimens (p=0.371, p=0.251 and p=0.288). C-reactive protein (CRP) and procalcitonin (PCT) increased on post-operative day (POD) 2: ∆max 29±5 mg/L (p<0.001) and ∆max 0.05±0.01 μg/L (p=0.005), respectively. Leucocytes increased at POD 1: ∆max 2.2±0.3 G/L (p<0.001). Albumin decreased at POD 2: ∆max -6.0±0.5 g/L (p<0.001). CRP increase correlated positively with Peritoneal Cancer Index (tumor load) (ρ =0.521, p<0.001).

Conclusion: PIPAC was followed by a modest and transitory inflammatory response that was commensurate to the disease extent. No hematological, renal or hepatic toxicity was observed even after repetitive administration.

Keywords: PIPAC, Peritoneal Carcinomatosis, Toxicity, Intraperitoneal Chemotherapy


Citation styles

APA
Teixeira Farinha, H., Grass, F., Labgaa, I., Pache, B., Demartines, N., Hübner, M. (2018). Inflammatory Response and Toxicity After Pressurized IntraPeritoneal Aerosol Chemotherapy. Journal of Cancer, 9(1), 13-20. https://doi.org/10.7150/jca.21460.

ACS
Teixeira Farinha, H.; Grass, F.; Labgaa, I.; Pache, B.; Demartines, N.; Hübner, M. Inflammatory Response and Toxicity After Pressurized IntraPeritoneal Aerosol Chemotherapy. J. Cancer 2018, 9 (1), 13-20. DOI: 10.7150/jca.21460.

NLM
Teixeira Farinha H, Grass F, Labgaa I, Pache B, Demartines N, Hübner M. Inflammatory Response and Toxicity After Pressurized IntraPeritoneal Aerosol Chemotherapy. J Cancer 2018; 9(1):13-20. doi:10.7150/jca.21460. https://www.jcancer.org/v09p0013.htm

CSE
Teixeira Farinha H, Grass F, Labgaa I, Pache B, Demartines N, Hübner M. 2018. Inflammatory Response and Toxicity After Pressurized IntraPeritoneal Aerosol Chemotherapy. J Cancer. 9(1):13-20.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image